KORU Medical Systems Inc (KRMD) Q3 2025: Everything You Need To Know Ahead Of Earnings

This article first appeared on GuruFocus.

KORU Medical Systems Inc (NASDAQ:KRMD) is set to release its Q3 2025 earnings on Nov 12, 2025. The consensus estimate for Q3 2025 revenue is $9.67 million, and the earnings are expected to come in at -$0.03 per share. The full year 2025's revenue is expected to be $39.94 million and the earnings are expected to be -$0.08 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 1 Warning Sign with KRMD.

Is KRMD fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for KORU Medical Systems Inc (NASDAQ:KRMD) have remained flat at $39.94 million for the full year 2025 and at $46 million for 2026 over the past 90 days. Similarly, earnings estimates have remained flat at -$0.08 per share for the full year 2025 and at -$0.02 per share for 2026 over the past 90 days.

In the previous quarter ending on June 30, 2025, KORU Medical Systems Inc's (NASDAQ:KRMD) actual revenue was $10.20 million, which beat analysts' revenue expectations of $9.46 million by 7.77%. KORU Medical Systems Inc's (NASDAQ:KRMD) actual earnings were $0 per share, which beat analysts' earnings expectations of -$0.026 per share by 100%. After releasing the results, KORU Medical Systems Inc (NASDAQ:KRMD) was up by 18.71% in one day.

Based on the one-year price targets offered by 5 analysts, the average target price for KORU Medical Systems Inc (NASDAQ:KRMD) is $5.60 with a high estimate of $7.00 and a low estimate of $4.00. The average target implies an upside of 42.86% from the current price of $3.92.

Based on GuruFocus estimates, the estimated GF Value for KORU Medical Systems Inc (NASDAQ:KRMD) in one year is $4.08, suggesting an upside of 4.08% from the current price of $3.92.

Based on the consensus recommendation from 5 brokerage firms, KORU Medical Systems Inc's (NASDAQ:KRMD) average brokerage recommendation is currently 2.2, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.

Scroll to Top